[3-1] Epigenome-wide discovery of DNA methylation biomarkers for liquid biopsy-based ovarian cancer screening

^○長谷川 仁美⁷, Harri Lempiäinen¹, Johannes Eichner¹, Michael Remmert², Marc Flesch², Tamas Rujan¹, Axel Schumacher², Benjamin Wahl⁴, Tobias Paprotka⁴, Allison Jones⁵, Iona Evans⁵, Shohreh Ghazali⁵, Michal Zikan⁶, David Cibula⁶, Mark Collins³, Martin Widschwendter⁵, Timo Wittenberger¹ (1.Genedata AG, 2.Genedata GmbH, 3.Genedata Inc, 4.GGATC Biotech AG, 5.Department of Women's Cancer, University College London,Elizabeth Garrett Anderson Institute for Women's Health, 6.Gynaecologic Oncology Center, Department of Obstetrics & Gynaecology, First Faculty of Medicine & General University Hospital, Charles University Prague, Prague, 7.Genedata KK)

Epigenomics、DNA methylation Biomarker、breast and ovarian cancer